THE PUTATIVE FACTOR-IX GENE PROMOTER IN HEMOPHILIA-B LEYDEN
- 1 September 1988
- journal article
- research article
- Vol. 72 (3) , 1074-1076
Abstract
Hemophilia B Leyden is characterized by low levels of factor IX antigen and activity before the age of 15, whereas after puberty factor IX levels rise at a rate of about 5% per year. A single base substituion (-A .fwdarw. T) at position -20 was identified in the putative promoter of the gene cloned from a patient with hemophilia B Leyden. This nucleotide change was confirmed in a second patient from the same pedigree and was also found in a patient from a second Dutch pedigree with the same hemophilic phenotype. The results indicate that the two Dutch kindreds are related and point to the functional significance of the -20 position for the expression of the human factor IX gene.This publication has 8 references indexed in Scilit:
- An Improved Method for Prenatal Diagnosis of Genetic Diseases by Analysis of Amplified DNA SequencesNew England Journal of Medicine, 1987
- Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5'-flanking region.Journal of Biological Chemistry, 1987
- The Prophylactic Treatment of Hemophilia B Leyden with Anabolic SteroidsAnnals of Internal Medicine, 1985
- Complete nucleotide sequences of the gene for human factor IX (antihemophilic factor B)Biochemistry, 1985
- The gene structure of human anti-haemophilic factor IX.The EMBO Journal, 1984
- In vitro characterization of the fibroin gene promoter by the use of single-base substitution mutants.Proceedings of the National Academy of Sciences, 1982
- Oral contraception and the detection of carriers in haemophilia BThrombosis Research, 1978
- The Inheritance of Christmas FactorBritish Journal of Haematology, 1962